However, additional genetic and molecular aberrations such as mutations in EGFR, p53, PTEN or other oncogenic driver events2–4,30,32,45 may be needed along with HDAC2 dysregulation for complete cellular transformation of normal stem cells into GBM like tumors. This evidence concerns the gene TP53 and glioblastoma.